BIOlogical agents: Strengthening the Adequate response to deliberate releases by the establishment of a Framework European-wide.
Desde 2006-07-01
hasta 2009-09-30
Detalles del proyecto
Coste total:
EUR 801 000Aportación de la UE:
EUR 801 000Coordinado en:
NetherlandsConvocatoria de propuestas:
FP6-2004-SSP-4See other projects for this callRégimen de financiación:
CA - Coordination actionObjetivo
Coordinador
NEDERLANDS VACCIN INSTITUUT (NETHERLANDS VACCINE INSTITUTE)
Netherlands
Antonie van Leeuwenhoeklaan 9-11
BILTHOVEN
Netherlands
BILTHOVEN
Netherlands
Participantes
HEALTH PROTECTION AGENCY CENTRE FOR EMERGENCY PREPAREDNESS AND RESPONSE
United Kingdom
NORWEGIAN INSTITUTE OF PUBLIC HEALTH
Norway
Geitmyrsveien 75
4404 Nydalen OSLO
Norway
4404 Nydalen OSLO
Norway
SMITTSKYDDSINSTITUTET (SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL)
Sweden
Nobel's Väg 18
SOLNA
Sweden
SOLNA
Sweden
STATENS SERUM INSTITUT
Denmark
Artillerivej 5
COPENHAGEN S
Denmark
COPENHAGEN S
Denmark
PAUL-EHRLICH-INSTITUT
Germany
Paul-Ehrlich-Str. 51 - 59
LANGEN
Germany
LANGEN
Germany
NOVARTIS VACCINES AND DIAGNOSTICS SRL
Italy
VIA FIORENTINA 1
SIENA
Italy
SIENA
Italy
"JOHAN BÉLA" NATIONAL CENTER FOR EPIDEMIOLOGY
Hungary
Gyáli út 2-6.
BUDAPEST
Hungary
BUDAPEST
Hungary
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA
Portugal
Av. Da República -EAN - Qta. Do Marquês
OEIRAS
Portugal
OEIRAS
Portugal
NATIONAL INSTITUTE OF PUBLIC HEALTH
Poland
Chelmska 30/34
WARSAW
Poland
WARSAW
Poland